UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000005903
Receipt number R000006982
Scientific Title Multicenter Phase II Clinical Study on the Safety and Efficacy of Nilotinib in Patients with Chronic Myelogenous Leukemia-Chronic Phase and Major Molecular Response
Date of disclosure of the study information 2011/07/01
Last modified on 2019/02/26 01:20:36

No. Disposal Last modified on Item of update
1 Insert 2011/07/01 20:56:20
2 Update 2011/07/01 21:29:58 Key inclusion criteria
3 Update 2011/07/29 21:24:40 Classification by malignancy
4 Update 2012/01/10 20:39:35 Key inclusion criteria
Key inclusion criteria
5 Update 2012/01/10 20:44:42 TEL
Institute
Institute
Organization
Organization
Category of Funding Organization
Tel1
6 Update 2012/07/02 15:01:01 Recruitment status
Date of protocol fixation
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results
Results
7 Update 2012/07/02 15:10:24 Recruitment status
Date of protocol fixation
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results
Results
8 Update 2013/01/01 14:29:09 Recruitment status
9 Update 2014/01/01 12:10:07 TEL
Email
Address
Address
TEL
10 Update 2014/10/27 22:27:33 Last name of lead principal investigator
Last name of lead principal investigator
TEL
Email
11 Update 2014/10/27 22:34:15 Public title
12 Update 2014/10/27 22:40:06 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
13 Update 2016/01/01 11:14:04 Recruitment status
Date trial data considered complete
Date analysis concluded
Publication of results
Results
Results
14 Update 2018/11/07 15:22:53 Name of primary person or sponsor
Organization
15 Update 2019/02/26 01:20:36 URL related to results and publications